West Branch Capital’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.5M Buy
29,650
+282
+1% +$52.3K 1.63% 18
2025
Q1
$6.15M Buy
29,368
+625
+2% +$131K 2.05% 12
2024
Q4
$5.11M Sell
28,743
-878
-3% -$156K 1.63% 16
2024
Q3
$5.85M Buy
29,621
+252
+0.9% +$49.8K 2.02% 12
2024
Q2
$5.04M Sell
29,369
-275
-0.9% -$47.2K 1.87% 11
2024
Q1
$5.4M Buy
29,644
+400
+1% +$72.8K 2.18% 10
2023
Q4
$4.53M Buy
29,244
+113
+0.4% +$17.5K 2.13% 11
2023
Q3
$4.34M Buy
29,131
+164
+0.6% +$24.4K 2.28% 9
2023
Q2
$3.9M Buy
28,967
+130
+0.5% +$17.5K 1.95% 12
2023
Q1
$4.6M Sell
28,837
-2
-0% -$319 2.56% 9
2022
Q4
$4.66M Sell
28,839
-2
-0% -$323 2.88% 9
2022
Q3
$3.87M Sell
28,841
-32
-0.1% -$4.3K 2.41% 10
2022
Q2
$4.42M Sell
28,873
-21
-0.1% -$3.22K 2.56% 9
2022
Q1
$4.68M Sell
28,894
-236
-0.8% -$38.3K 2.24% 9
2021
Q4
$3.94M Sell
29,130
-2
-0% -$271 1.68% 15
2021
Q3
$3.14M Buy
29,132
+2,275
+8% +$245K 1.51% 16
2021
Q2
$3.03M Buy
26,857
+574
+2% +$64.7K 1.49% 17
2021
Q1
$2.84M Sell
26,283
-911
-3% -$98.6K 1.66% 19
2020
Q4
$2.91M Sell
27,194
-59
-0.2% -$6.32K 1.72% 16
2020
Q3
$2.39M Buy
27,253
+259
+1% +$22.7K 1.52% 19
2020
Q2
$2.65M Buy
26,994
+449
+2% +$44.1K 1.87% 14
2020
Q1
$2.02M Sell
26,545
-1,061
-4% -$80.8K 1.93% 15
2019
Q4
$2.44M Sell
27,606
-3,968
-13% -$351K 1.7% 16
2019
Q3
$2.39M Buy
31,574
+6,903
+28% +$523K 1.77% 14
2019
Q2
$1.79M Sell
24,671
-4,740
-16% -$345K 1.48% 17
2019
Q1
$2.37M Buy
29,411
+2,031
+7% +$164K 2.12% 13
2018
Q4
$2.52M Sell
27,380
-807
-3% -$74.4K 2.66% 9
2018
Q3
$2.67M Sell
28,187
-1,463
-5% -$138K 1.98% 14
2018
Q2
$2.75M Buy
29,650
+3,375
+13% +$313K 2.17% 13
2018
Q1
$2.49M Buy
+26,275
New +$2.49M 2.73% 11